KDM1A and neoplasm: They observed the increased expression of CCR7 and CD38 (M1 markers) and the decreased expression of CD206 and EGR2 (M2 markers) in the MDA-MB-231 tumor tissues following treatment with LSD1 inhibitor phenelzine (57).